MicroRNA-770-5p contributes to podocyte injury via targeting E2F3 in diabetic nephropathy

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
Juanjuan GuoShaoli Wang

Abstract

Diabetic nephropathy (DN) has been identified as the major cause of end-stage renal disease (ESRD) in most developed countries. MicroRNA-770-5p depletion could repress high glucose (HG)-triggered apoptosis in podocytes, and downregulation of E2F transcription factor 3 (E2F3) could facilitate podocyte injury. Nevertheless, whether E2F3 is involved in miR-770-5p knockdown-mediated improvement of DN is still unclear. The expression levels of miR-770-5p and E2F3 were detected in HG-treated podocytes by RT-qPCR. The expression levels of E2F3, apoptosis-related proteins Bcl-2 related X protein (Bax), B-cell lymphoma-2 (Bcl-2), Bad, apoptotic peptidase activating factor 1 (APAF1), C-caspase3, C-caspase7, and C-caspase9 were detected by western blot assay. The effects of miR-770-5p and E2F3 on HG-treated podocytes proliferation and apoptosis were detected by CCK-8 and flow cytometry assays. The interaction between miR-770-5p and E2F3 was predicted by Targetscan, and then verified by the dual-luciferase reporter assay. MiR-770-5p was upregulated and E2F3 was downregulated in HG-treated podocytes. MiR-770-5p inhibited proliferation and promoted apoptosis and E2F3 promoted proliferation and suppressed apoptosis in HG-treated podocytes. E2...Continue Reading

References

Oct 26, 2000·Nature·M O Hengartner
Jun 5, 2001·Nature Cell Biology·M C MoroniK Helin
Nov 17, 2009·Diabetes Research and Clinical Practice·Gojka Roglic, Nigel Unwin
Nov 18, 2009·Molecular and Cellular Biology·Luis A MartinezAnne Chauchereau
Mar 3, 2011·PloS One·Espen EnerlyAnne-Lise Børresen-Dale
May 25, 2011·The Journal of Clinical Investigation·Agnes B Fogo
Apr 17, 2015·Annals of the New York Academy of Sciences·Mitsuo Kato, Rama Natarajan
May 17, 2015·Advanced Drug Delivery Reviews·Scott M Hammond
Mar 2, 2016·PloS One·Denis DelićRichard Urquhart
Mar 15, 2016·Current Diabetes Reports·Kate SimpsonTimothy Bowen
Feb 6, 2018·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kausik Umanath, Julia B Lewis
Jun 26, 2018·Biochemical Pharmacology·Saikat Dewanjee, Niloy Bhattacharjee
Jun 26, 2018·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Xu HanYinyan Li
Sep 14, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaoping ChenBo Lin
Jan 12, 2019·Reproductive Biology and Endocrinology : RB&E·Jinbi ZhangZengxiang Pan
Mar 6, 2019·Journal of Cellular Biochemistry·Fangfang ZhaShoujun Bai

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry
electrophoresis
Transfection
Flow

Software Mentioned

SPSS
TargetScan

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis